Variation in Antibiotic Treatment Failure Outcome Definitions in Randomised Trials and Observational Studies of Antibiotic Prescribing Strategies: A Systematic Review and Narrative Synthesis.
observational study
randomised trial
treatment failure
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
06 May 2022
06 May 2022
Historique:
received:
16
03
2022
revised:
28
04
2022
accepted:
30
04
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Antibiotic treatment failure is used as an outcome in randomised trials and observational studies of antibiotic treatment strategies and may comprise different events that indicate failure to achieve a desired clinical response. However, the lack of a universally recognised definition has led to considerable variation in the types of events included. We undertook a systematic review of published studies investigating antibiotic treatment strategies for common uncomplicated infections, aiming to describe variation in terminology and components of the antibiotic treatment failure outcomes. We searched Medline, Embase, and the Cochrane Central Register of Clinical trials for English language studies published between January 2010 and January 2021. The population of interest was ambulatory patients seen in primary care or outpatient settings with respiratory tract (RTI), urinary tract (UTI), or skin and soft tissue infection (SSTI), where different antibiotic prescribing strategies were compared, and the outcome was antibiotic treatment failure. We narratively summarised key features from eligible studies and used frequencies and proportions to describe terminology, components, and time periods used to ascertain antibiotic treatment failure outcomes. Database searches identified 2967 unique records, from which 36 studies met our inclusion criteria. This included 10 randomised controlled trials and 26 observational studies, with 20 studies of RTI, 12 of UTI, 4 of SSTI, and 2 of both RTI and SSTI. We identified three key components of treatment failure definitions: prescription changes, escalation of care, and change in clinical condition. Prescription changes were most popular in studies of UTI, while changes in clinical condition were most common in RTI and SSTI studies. We found substantial variation in the definition of antibiotic treatment failure in included studies, even amongst studies of the same infection subtype and study design. Considerable further work is needed to develop a standardised definition of antibiotic treatment failure in partnership with patients, clinicians, and relevant stakeholders.
Identifiants
pubmed: 35625271
pii: antibiotics11050627
doi: 10.3390/antibiotics11050627
pmc: PMC9137992
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
CMAJ. 2015 Jun 16;187(9):648-656
pubmed: 25918178
Hosp Pract (1995). 2017 Feb;45(1):1-8
pubmed: 28064542
J Antimicrob Chemother. 2014 Jul;69(7):1954-9
pubmed: 24648506
Br J Clin Pharmacol. 2010 Sep;70(3):418-28
pubmed: 20716243
Open Forum Infect Dis. 2020 Feb 26;7(3):ofaa065
pubmed: 32195289
Pediatr Infect Dis J. 2015 Aug;34(8):839-42
pubmed: 25955834
PLoS One. 2015 Aug 25;10(8):e0136232
pubmed: 26305908
JAMA. 2018 May 1;319(17):1781-1789
pubmed: 29710295
Int J Prev Med. 2013 Oct;4(10):1162-8
pubmed: 24319556
BMJ. 2014 Sep 23;349:g5493
pubmed: 25249162
Emerg Med J. 2018 Aug;35(8):492-498
pubmed: 29914924
Antibiotics (Basel). 2016 Jul 04;5(3):
pubmed: 27384588
Am Pract Dig Treat. 1946 Sep;1(1):45
pubmed: 20996993
Pediatr Pulmonol. 2016 May;51(5):541-8
pubmed: 26367389
Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):301-309
pubmed: 27862588
J Antimicrob Chemother. 2019 Nov 1;74(11):3337-3343
pubmed: 31504584
Int J Antimicrob Agents. 2009 Aug;34 Suppl 3:S14-9
pubmed: 19596109
Adv Ther. 2010 Oct;27(10):743-55
pubmed: 20799007
J Med Assoc Thai. 2015 Oct;98(10):974-84
pubmed: 26638589
Medicine (Baltimore). 2015 Sep;94(39):e1662
pubmed: 26426664
Open Forum Infect Dis. 2019 Jan 18;6(3):ofz039
pubmed: 30882011
JAMA. 2017 May 23;317(20):2088-2096
pubmed: 28535235
Curr Med Res Opin. 2016 Jun;32(6):1023-32
pubmed: 26907677
EClinicalMedicine. 2019 Aug 12;14:23-31
pubmed: 31709399
Clin Microbiol Infect. 2020 Oct;26(10):1355-1360
pubmed: 32165321
Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):857-866
pubmed: 31050078
Pediatr Infect Dis J. 2014 Feb;33(2):136-42
pubmed: 23989106
Scand J Prim Health Care. 2020 Sep;38(3):291-299
pubmed: 32686974
N Engl J Med. 2020 Jul 2;383(1):24-34
pubmed: 32609980
Intensive Care Med. 2018 Jan;44(1):73-75
pubmed: 29032500
Pediatrics. 2011 Sep;128(3):e479-87
pubmed: 21844058
Am J Syph Gonorrhea Vener Dis. 1948 May;32(3):233-42
pubmed: 18912212
J Antimicrob Chemother. 2019 Sep 1;74(9):2767-2773
pubmed: 31098630
Open Access Maced J Med Sci. 2018 Aug 16;6(8):1419-1422
pubmed: 30159068
Clin Infect Dis. 2011 Feb 1;52(3):293-300
pubmed: 21189270
Clin Infect Dis. 2019 Jul 18;69(3):397-404
pubmed: 30596964
Trials. 2019 Feb 7;20(1):106
pubmed: 30732617
JAMA. 2017 Dec 19;318(23):2325-2336
pubmed: 29260224